Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017-Reference-Cited by-同舟云学术

Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017

Published:2019-01-21 Issue:3 Volume:85 Page:634-643
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bonaldo Giulia¹,Vaccheri Alberto¹,D'Annibali Ottavio¹,Motola Domenico¹^ORCID

Affiliation:

1. Unit of Pharmacology, Department of Medical and Surgical SciencesUniversity of Bologna via Irnerio 48 40126 Bologna Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13841

Reference42 articles.

1. World Health Organization.Human papillomavirus vaccines: WHO position paper October 2014–Recommendations.

2. European Centre for Disease Prevention and Control.ECDC guidance. Introduction of HPV vaccines in European Union countries: an update.2012. Available athttp://ecdc.europa.eu/en/publications/Publications/20120905_GUI_HPV_vaccine_update.pdf(last accessed 5 October 2018).

3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

4. Global cancer statistics

5. Sexually Transmitted Infections Among US Women and Men

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study;Vaccine: X;2024-08

2. Opportunities and challenges for human papillomavirus vaccination in China;Human Vaccines & Immunotherapeutics;2024-04-04

3. Unveiling the Therapeutic Horizon: HPV Vaccines and Their Impact on Cutaneous Diseases—A Comprehensive Review;Vaccines;2024-02-23

4. Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A nationally representative cross-sectional survey;Vaccine;2023-11

5. Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis;Frontiers in Pharmacology;2023-04-13